These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37302791)

  • 1. Basophil Activation Test in Double-Sensitized Patients With Hymenoptera Venom Allergy: Additional Benefit of Component-Resolved Diagnostics.
    Schmidle P; Blank S; Altrichter S; Hoetzenecker W; Brockow K; Darsow U; Biedermann T; Eberlein B
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2890-2899.e2. PubMed ID: 37302791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy.
    Müller U; Schmid-Grendelmeier P; Hausmann O; Helbling A
    Allergy; 2012 Aug; 67(8):1069-73. PubMed ID: 22676144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice.
    Engin A; Oktelik FB; Gelincik A; Sin A; Sin BA; Dursun BA; Beyaz S; Gorgulu B; Cetin E; Deniz G
    Allergy Asthma Proc; 2021 Jul; 42(4):350-356. PubMed ID: 34187627
    [No Abstract]   [Full Text] [Related]  

  • 4. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
    Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
    Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic precision of component-resolved vs. extract-based in vitro diagnosis of hymenoptera venom allergy: effects on clinical management.
    Seyfarth F; Miguel D; Schliemann S; Hipler UC
    J Dtsch Dermatol Ges; 2017 May; 15(5):507-515. PubMed ID: 28485877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
    Müller UR; Johansen N; Petersen AB; Fromberg-Nielsen J; Haeberli G
    Allergy; 2009 Apr; 64(4):543-8. PubMed ID: 19120073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Component Resolved Diagnosis in Hymenoptera Anaphylaxis.
    Tomsitz D; Brockow K
    Curr Allergy Asthma Rep; 2017 Jun; 17(6):38. PubMed ID: 28501976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy.
    Jakob T; Rauber MM; Perez-Riverol A; Spillner E; Blank S
    Curr Allergy Asthma Rep; 2020 Jun; 20(9):48. PubMed ID: 32548726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
    Blank S; Seismann H; Bockisch B; Braren I; Cifuentes L; McIntyre M; Rühl D; Ring J; Bredehorst R; Ollert MW; Grunwald T; Spillner E
    J Immunol; 2010 May; 184(9):5403-13. PubMed ID: 20348419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of laboratory testing for the diagnosis of Hymenoptera venom allergy.
    Vachová M; Panzner P; Malkusová I; Hanzlíková J; Vlas T
    Allergy Asthma Proc; 2016 May; 37(3):248-55. PubMed ID: 27178893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.
    Arzt L; Bokanovic D; Schrautzer C; Laipold K; Möbs C; Pfützner W; Herzog SA; Vollmann J; Reider N; Bohle B; Aberer W; Sturm GJ
    Allergy; 2018 Jun; 73(6):1223-1231. PubMed ID: 29171032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophil activation test as alternative method to CAP-inhibition in patients with double sensitization to vespid venoms.
    Cabrera CM; Palacios-Cañas A; Joyanes-Romo JB; Urra JM; Mur P
    Mol Immunol; 2022 Sep; 149():59-65. PubMed ID: 35749834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy.
    Eberlein-König B; Rakoski J; Behrendt H; Ring J
    J Investig Allergol Clin Immunol; 2004; 14(1):10-6. PubMed ID: 15160437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosis.
    Gattinger P; Lupinek C; Kalogiros L; Silar M; Zidarn M; Korosec P; Koessler C; Novak N; Valenta R; Mittermann I
    PLoS One; 2018; 13(6):e0199250. PubMed ID: 29940036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
    Neis MM; Merk HF
    Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cross reactions between Hymenoptera venoms from different families, genera and species].
    Hemmer W
    Hautarzt; 2014 Sep; 65(9):775-9. PubMed ID: 25234625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tricky cases in in-vitro diagnostics of hymenoptera venom allergy].
    Müller S; Rafei-Shamsabadi D; Jakob T
    Hautarzt; 2014 Sep; 65(9):780-1, 784-90. PubMed ID: 25234626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Component-resolved diagnosis of wasp (yellow jacket) venom allergy.
    Ebo DG; Faber M; Sabato V; Leysen J; Bridts CH; De Clerck LS
    Clin Exp Allergy; 2013 Feb; 43(2):255-61. PubMed ID: 23331567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vespa velutina nigrithorax venom allergy: inhibition studies approach for the choice of specific immunotherapy.
    Grossi V; Severino M; Massolo A; Infantino M; Laureti F; Macchia D; Meucci E; Francescato E; Pantera B; Ebbli A; Fumagalli F; Lari B; Perri A; Liotti I; Ciotta G; Terenzi G; Valeva SV; Consolati M; Folgore T; Manfredi M
    Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):161-165. PubMed ID: 36515256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.